蜜桃传媒app

Sidong Huang is an Associate Professor in the Department of Biochemistry and Rosalind and Morris Goodman Cancer Institute at McGill University. He is also the scientific director of the McGill Platform for Cellular Perturbation. Huang obtained his PhD in Biochemistry and Molecular Biology from the University of California, San Francisco in 2003, under the supervision of Dr. Erin O鈥橲hea. He then joined the laboratory of Dr. Rene Bernards at the Netherlands Cancer Institute for his postdoctoral training focusing on functional genetics in cancer. In 2013, he established his independent research group at McGill University, using functional genomic tools to study cancer-relevant pathways and to guide cancer therapy. Huang鈥檚 work has uncovered novel resistance mechanisms to cancer therapeutics, identified new treatment strategies, and led to the establishment of clinical trials. His current research targets hard-to-treat cancers, particularly those associated with deficiencies in the SWI/SNF chromatin remodeling complexes.